AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coller, M.
Right arrow Articles by McInnes, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coller, M.
Right arrow Articles by McInnes, M. M.
Related Collections
Right arrow Other Health Financing
Right arrow Health Law
Right arrow Health Policy
Right arrow Other Tobacco
June 2002, Vol 92, No. 6 | American Journal of Public Health 984-989
© 2002 American Public Health Association


RESEARCH AND PRACTICE

Evaluating the Tobacco Settlement Damage Awards: Too Much or Not Enough?

Maribeth Coller, PhD, Glenn W. Harrison, PhD and Melayne Morgan McInnes, PhD

The authors are with the Moore School of Business, University of South Carolina, Columbia.

Correspondence: Requests for reprints should be sent to Glenn W. Harrison, PhD, Department of Economics, Moore School of Business, University of South Carolina, Columbia, SC 29208 (e-mail: harrison{at}moore.badm.sc.edu).

Objectives. This study compared the present economic value of the 1998 tobacco settlement with the present economic value of the damages attributable to tobacco.

Methods. The 1987 National Medical Expenditure Survey was used to estimate the smoking attributable fraction (SAF) of medical expenditures. SAFs were then applied to Medicaid and other expenditures.

Results. Settlement payments covered only 40% of Medicaid treatment costs already incurred and only 30% of past and projected future Medicaid costs. Excess medical expenditures for all other payment sources were roughly comparable to those incurred by Medicaid.

Conclusions. Although the settlement may reduce future smoking prevalence rates by limiting the ability of tobacco companies to promote smoking and by raising cigarette prices, euphoria over the huge settlement funds should be balanced by a sober comparison with the even larger damage amounts.




This article has been cited by other articles:


Home page
Tobacco ControlHome page
W. Max and T. Tsoukalas
Economics on trial: the use and abuse of economic methods in third party tobacco litigation
Tob. Control, December 1, 2006; 15(suppl_4): iv77 - iv83.
[Abstract] [Full Text] [PDF]


Home page
Journal of Health Politics, Policy and LawHome page
F. A. Sloan, E. S. Carlisle, J. R. Rattliff, and J. Trogdon
Determinants of States' Allocations of the Master Settlement Agreement Payments
Journal of Health Politics Policy and Law, August 1, 2005; 30(4): 643 - 686.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Public Health Association